Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice.
about
Adiponectin regulates albuminuria and podocyte function in miceGetting 'Smad' about obesity and diabetesFibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markersInhibition of transforming growth factor-beta1-induced signaling and epithelial-to-mesenchymal transition by the Smad-binding peptide aptamer Trx-SARAOxidative Stress in Diabetic Nephropathy with Early Chronic Kidney DiseaseSerum TGF-β1 as a Biomarker for Type 2 Diabetic Nephropathy: A Meta-Analysis of Randomized Controlled TrialsHypoxia: The Force that Drives Chronic Kidney DiseaseHistological changes of kidney in diabetic nephropathyMolecular mechanisms of renal blood flow autoregulationInhibitors/antagonists of TGF-β system in kidney fibrosisDiabetic nephropathy and extracellular matrixNew experimental models of diabetic nephropathy in mice models of type 2 diabetes: efforts to replicate human nephropathyHeme oxygenase-1 as a target for TGF-β in kidney diseaseCulture-modified bone marrow cells attenuate cardiac and renal injury in a chronic kidney disease rat model via a novel antifibrotic mechanismPericytes, an overlooked player in vascular pathobiologyRodent models of diabetic nephropathy: their utility and limitationsStop chronic kidney disease progression: Time is approachingRegulation and physiological roles of serum- and glucocorticoid-induced protein kinase isoformsRecombinant soluble betaglycan is a potent and isoform-selective transforming growth factor-beta neutralizing agentTGF-beta: a crucial component of the pathogenesis of diabetic nephropathyOral administration of GW788388, an inhibitor of transforming growth factor beta signaling, prevents heart fibrosis in Chagas diseaseA purpose-synthesised anti-fibrotic agent attenuates experimental kidney diseases in the ratHistone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injuryInvolvement of transforming growth factor-beta in regulation of calcium transients in diabetic vascular smooth muscle cellsEpigenetic histone methylation modulates fibrotic gene expressionTGFβ-stimulated microRNA-21 utilizes PTEN to orchestrate AKT/mTORC1 signaling for mesangial cell hypertrophy and matrix expansionThe role of renin-angiotensin-aldosterone system inhibition in chronic kidney disease.Discovery of genes related to diabetic nephropathy in various animal models by current techniques.Therapeutic Modalities in Diabetic Nephropathy: Future Approaches.Mesangial pathology in glomerular disease: targets for therapeutic intervention.Targeted renal therapies through microbubbles and ultrasound.Direct evidence for intrarenal chymase-dependent angiotensin II formation on the diabetic renal microvasculature.Resequencing of genes for transforming growth factor beta1 (TGFB1) type 1 and 2 receptors (TGFBR1, TGFBR2), and association analysis of variants with diabetic nephropathy.Hypoxia response and VEGF-A expression in human proximal tubular epithelial cells in stable and progressive renal disease.Major role for ACE-independent intrarenal ANG II formation in type II diabetes.Mechanisms of metabolic memory and renal hypoxia as a therapeutic target in diabetic kidney disease.Candesartan Differentially Regulates Epithelial Sodium Channel in Cortex Versus Medulla of Streptozotocin-Induced Diabetic RatsGene expression programs of mouse endothelial cells in kidney development and disease.Periostin-Binding DNA Aptamer Treatment Ameliorates Peritoneal Dialysis-Induced Peritoneal FibrosisGinger extract diminishes chronic fructose consumption-induced kidney injury through suppression of renal overexpression of proinflammatory cytokines in rats
P2860
Q24324384-EE419CA4-DFAF-44B7-A6F6-9D3562F60670Q24630117-ECCF78C3-D352-4B76-B7F3-F7FB3B6936DFQ24644869-32CA9F05-6EB7-4040-96FE-99902067DA0AQ24671742-867A86BE-289A-438C-B922-505E940D1BE1Q26741451-DB58502A-AFB8-42EE-8442-9160F780F9FDQ26768469-06FF8088-1FD8-4411-AA36-805D22E271E8Q26768865-652CC633-1492-4E37-A496-2BEC57072AE8Q26773633-C07049A6-08D1-482A-B2CE-7945885CC695Q26825286-BCCDE5C2-D206-4065-9111-0A9A6EE67A59Q26852400-B972CC1D-8D60-4028-B427-3E24336FE3E0Q26996008-F26E6554-6285-439F-8135-A6E98E1FF414Q26996084-13ADAF60-F5C1-4647-A14A-CDCCB2A2913DQ26998726-B33BF6A2-FCD1-4847-9126-D1F90708ED06Q27333630-A3F09DDD-BC7B-45EB-B169-C28621892182Q28070053-4C358877-572F-4EF3-B1AF-4C0981C1AC34Q28073885-610958A7-0080-419F-8352-BBF710946D03Q28078020-591683A7-D1D5-4152-8E70-F973739727D1Q28205154-23F91C4E-6AC6-4A25-80B9-C3B7EB64B48EQ28360679-706BCA20-8458-4933-8215-10AE07616C0FQ28367170-3DA6A18E-D761-402F-8DF5-96D08F522B22Q28484212-304A2B4B-3659-4350-9D4F-357E50645E2CQ28484321-7515FB43-AEB4-4D8C-9A99-A221E3CD8B57Q28569252-23A27FEA-BC1D-4141-849E-D83DDDAA6616Q28574951-FDA2BD89-AD1C-4A8B-8D7E-3A17DDB6FEAEQ28579049-FA1B3BFB-246D-4DFB-8739-66E9459DB200Q28975741-938E7CF5-35F7-482C-BFBB-7BFD732FC412Q30340930-420B74E5-C988-45F4-AED7-010C1541533FQ30398783-49D4174D-3337-45C2-BC2F-161EBD5A94E2Q30423005-53DDF553-4AB6-4D05-8E0F-5B717799A1B0Q30429535-B0D8280D-0825-46CD-9B15-424C5573018CQ30472688-1DDE9DBC-A1F5-475F-89C5-1D2CB3245974Q30533827-47268EB5-6033-49B9-9D61-9A0974D84E60Q30830157-0CA44853-80C9-4C34-9472-3A3C9E11A47FQ33399420-3388E7B9-5593-400E-A53E-168CD699A0E7Q33589120-066B64A1-9D41-48FF-838C-604567AD836AQ33633674-2D0834BC-D9DF-48C1-A1EB-064B9743AA21Q33643812-944D9B44-E7CB-44E4-A06C-B7B9C22597F4Q33656631-CACCDA27-6262-4E8D-B712-E62D64E723F0Q33701827-7A064BEC-C5E9-419A-B491-A1C99102C0E9Q33716952-721749B3-2D03-4EAE-8AF0-D767A282A462
P2860
Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Long-term prevention of renal ...... tibody in db/db diabetic mice.
@ast
Long-term prevention of renal ...... tibody in db/db diabetic mice.
@en
type
label
Long-term prevention of renal ...... tibody in db/db diabetic mice.
@ast
Long-term prevention of renal ...... tibody in db/db diabetic mice.
@en
prefLabel
Long-term prevention of renal ...... tibody in db/db diabetic mice.
@ast
Long-term prevention of renal ...... tibody in db/db diabetic mice.
@en
P2093
P2860
P356
P1476
Long-term prevention of renal ...... tibody in db/db diabetic mice.
@en
P2093
B B Hoffman
F N Ziyadeh
M C Iglesias-De La Cruz
T A McGowan
P2860
P304
P356
10.1073/PNAS.120055097
P407
P577
2000-07-01T00:00:00Z